PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Dubai Health Authority, Dubai, United Arab Emirates.\', \'Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates.\', \'Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.\', \'Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.\', \'Prince Abdullah Ben Khaled Celiac Disease Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0258643
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34699552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all